US President Threatens Potent Tariffs on Imported Pharmaceuticals Amidst Ongoing Price Negotiations
The United States President has initiated a significant policy shift, leveraging the threat of substantial tariffs, including a potential 100 percent levy on certain patented pharmaceuticals, to compel pharmaceutical companies…







